Interleukin 2 leads to dose-dependent expression of the alpha chain of the IL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation

Clinical Immunology

Volumn 97, Issue 3, 2000, Pages 266-276

  Sereti, Irini ^a   Gea Banacloche, Juan ^a   Kan, Min Ying ^a   Hallahan, Claire W ^a   Lane, H Clifford ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cell surface molecules; Cellular activation; Cytokine receptors; Cytokines; T lymphocytes

Indexed keywords

CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0033664851     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4929     Document Type: Article

References (49)

1. Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component
2. Human B lymphocytes express the p75 component of the interleukin 2 receptor
3. Recombinant interleukin-2-induced polyclonal proliferation of in vitro un-stimulated human peripheral blood lymphocytes
4. Direct activation of human resting T cells by IL 2: The role of an IL 2 receptor distinct from the Tac protein
5. Activation and proliferation of CD8+ T cells in lymphoid tissues of HIV-1infected individuals in the absence of the high-affinity IL- 2 receptor
6. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells
7. Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons
8. A randomized trial of high- versus low-dose subcutaneous interleukin- 2 outpatient therapy for early human immunodeficiency virus type 1 infection
9. Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets
10. Kinetics of lymphokine produc tion in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2
11. Granulocyte-macrophage colony-stimulating factor: Potential therapeutic, immunological and antiretroviral effects in HIV infection
12. Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: Correlation with clinical toxicity
13. Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL- 2
14. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL- 15
15. Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells
16. Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients
17. Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity
18. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1
19. The interleukin-2 receptor complex and signal transduction: Role of the beta-chain
20. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study
21. Controlled trial of interleukin-2 infusionsin patients infected with the human immuno-deficiency virus
22. Visualizing memory phenotype development after in vitro stimulation of CD4(+) T cells
23. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment
24. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: Implications for X-linked severe combined immunodeficiency (XSCID)
25. Production of granulocyte/macrophage-colony stimulating factor by human natural killer cells. Modulation by the p 75 subunit of the interleukin 2 receptor and by the CD2 receptor
26. Determination of lymphocyte division by flow cytometry
27. The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation
28. The purification and properties of human T cell growth factor
29. Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients
30. Selective in vitro growth of T lymphocytes from normal human bone marrows
31. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation
32. Biology of the interleukin- 2 receptor
33. Phorbol esters down-regulate transcription and translation of the CD 4 gene
34. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans
35. Synergistic activation of CD4+ T cells by IL-16 and IL- 2
36. Activation of natural killer cells via the p 75 interleukin 2 receptor
37. Pharmacokinetics and pharmacody namics of subcutaneous interleukin-2 in HIV-infected patients
38. Following antigen challenge, T cells up-regulate cell surface expression of CD 4 in vitro and in vivo
39. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
40. The IL-2 receptor beta chain (p70): Role in mediating signals for LAK, NK, and proliferative activities
41. Interleukin-2 toxicity
42. Concomitant therapy with subcutaneous interleukin- 2 and zidovudine plus didanosine in patients with early stage HIV infection
43. Interleukin-2: Inception, impact, and implications
44. Rational interleukin-2 therapy
45. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood
46. Antigen-independent activation of naive and memory resting T cells by a cytokine combination
47. Interleukin- 2 apparently upregulates its receptor and induces proliferation of various resting mononuclear leukocytes in the absence of antigen
48. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death
49. Circulating human T and B lymphocytes express the p55 interleukin-2 receptor molecule (TAC, CD25)